More than 20 states have passed so-called "Right-to-Try" laws that give terminally ill patients access to experimental drugs. What bypassing the F.D.A. could mean for clinical trials, treatment outcomes and patient safety.
Earlier this year, Jeffrey Dvorkin became National Public Radio’s first ombudsman. In this position, he represents the listeners’ interests within NPR. He’ll join Diane to talk about some of the issues he’s tackled so far, to welcome questions and comments on NPR’s programming, and to explain how he’s working to keep the "public" in National Public Radio.
- Jeffrey Dvorkin Ombudsman for National Public Radio Send e-mail for Jeffrey Dvorkin to firstname.lastname@example.org
Most Recent Shows
World leaders meet for the UN climate change summit in Paris to discuss plans for reducing carbon emissions. What's at stake for the talks, and prospects for a major agreement.
A molecular-biologist-turned-Buddhist-monk says altruism is the answer to many of the world's most pressing challenges. Can concern for others help solve wealth inequality, climate change and world hunger?
Kate Mulgrew, who stars as "Red" in the Netflix TV series "Orange Is The New Black", opens up in a new memoir about her complicated family and the baby she gave away for adoption as a young woman.